Consideraciones de seguridad en la prescripción de medicamentos antiinflamatorios no esteroideos (AINEs), a través de una revisión de revisiones sistemáticas

Autores/as

  • A. Olry de Labry Lima Andalusian School of Public Health (EASP). Campus Universitario de Cartuja. Granada. Spain.
  • E. Salamanca-Fernández Radiology and Physical Medicine Department. University of Granada. Granada. Spain.
  • E.J. Alegre del Rey Pharmacy Service. Hospital Universitario Puerto Real. Cádiz. Spain.
  • A. Matas Hoces Andalusian School of Public Health (EASP). Campus Universitario de Cartuja. Granada. Spain.
  • M.Á. González Vera Farmacia del Puente. Pinos Puente. Granada. Spain.
  • C. Bermúdez Tamayo Andalusian School of Public Health (EASP). Campus Universitario de Cartuja. Granada. Spain.

DOI:

https://doi.org/10.23938/ASSN.0965

Palabras clave:

AINEs, Enfermedad cardiovascular, Hipertensión, Revisión paraguas

Resumen

Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most widely used drugs worldwide. This makes it necessary to carry out a comprehensive synthesis of the available evidence on the safe and adequate prescription of NSAIDs in patients with cardiovascular disease, chronic kidney disease, hypertension, heart failure or liver cirrhosis and in general population. For this, a review of systematic reviews was carried out. Data extraction and analysis were performed independently by two reviewers and a narrative synthesis of the results was carried out. The use of NSAIDs is associated with a significantly higher probability of hepatotoxicity and kidney damage, as well as increased risk of exacerbation of heart failure. Taking into account the increased cardiovascular, liver and kidney risk, the prescription of NSAIDs should be carried out with caution, considering the treatment duration and the patient’s situation. For this reason, patients should be informed about their possible health consequences as well as ensuring adequate monitoring of them.

Biografía del autor/a

A. Olry de Labry Lima, Andalusian School of Public Health (EASP). Campus Universitario de Cartuja. Granada. Spain.

CIBER of Epidemiology and Public Health (CIBERESP). Spain.

Instituto de Investigación Biosanitaria de Granada. Granada. Spain.

E. Salamanca-Fernández, Radiology and Physical Medicine Department. University of Granada. Granada. Spain.

 

2. CIBER of Epidemiology and Public Health (CIBERESP). Spain.

3. Instituto de Investigación Biosanitaria de Granada. Granada. Spain.

A. Matas Hoces, Andalusian School of Public Health (EASP). Campus Universitario de Cartuja. Granada. Spain.

CADIME: Andalusian Medicine Information Center. Granada. Spain.

C. Bermúdez Tamayo, Andalusian School of Public Health (EASP). Campus Universitario de Cartuja. Granada. Spain.

CIBER of Epidemiology and Public Health (CIBERESP). Spain

Instituto de Investigación Biosanitaria de Granada. Granada. Spain.

Publicado

2021-08-20

Cómo citar

Olry de Labry Lima, A., Salamanca-Fernández, E., Alegre del Rey, E., Matas Hoces, A., González Vera, M., & Bermúdez Tamayo, C. (2021). Consideraciones de seguridad en la prescripción de medicamentos antiinflamatorios no esteroideos (AINEs), a través de una revisión de revisiones sistemáticas. Anales Del Sistema Sanitario De Navarra, 44(2), 261–273. https://doi.org/10.23938/ASSN.0965